This report contains market size and forecasts of Drug Repositioning in Global, including the following market information:
Global Drug Repositioning Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Drug Repositioning market was valued at 25680 million in 2020 and is projected to reach US$ 30630 million by 2027, at a CAGR of 4.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Repositioning companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Repositioning Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Drug Repositioning Market Segment Percentages, By Type, 2020 (%)
Generic Drugs
Clinical Trial Failed Drugs
China Drug Repositioning Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Drug Repositioning Market Segment Percentages, By Application, 2020 (%)
Cardiovascular Diseases
Mental Illness
Cancer
Others
Global Drug Repositioning Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Drug Repositioning Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Drug Repositioning Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Drug Repositioning Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Repositioning Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Repositioning Overall Market Size
2.1 Global Drug Repositioning Market Size: 2021 VS 2027
2.2 Global Drug Repositioning Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in Global Market
3.2 Top Global Drug Repositioning Companies Ranked by Revenue
3.3 Global Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in Global Market, by Revenue in 2020
3.5 Global Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in Global Market
3.6.1 List of Global Tier 1 Drug Repositioning Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Repositioning Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drug Repositioning Market Size Markets, 2021 & 2027
4.1.2 Generic Drugs
4.1.3 Clinical Trial Failed Drugs
4.2 By Type - Global Drug Repositioning Revenue & Forecasts
4.2.1 By Type - Global Drug Repositioning Revenue, 2016-2021
4.2.2 By Type - Global Drug Repositioning Revenue, 2022-2027
4.2.3 By Type - Global Drug Repositioning Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Repositioning Market Size, 2021 & 2027
5.1.2 Cardiovascular Diseases
5.1.3 Mental Illness
5.1.4 Cancer
5.1.5 Others
5.2 By Application - Global Drug Repositioning Revenue & Forecasts
5.2.1 By Application - Global Drug Repositioning Revenue, 2016-2021
5.2.2 By Application - Global Drug Repositioning Revenue, 2022-2027
5.2.3 By Application - Global Drug Repositioning Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Drug Repositioning Market Size, 2021 & 2027
6.2 By Region - Global Drug Repositioning Revenue & Forecasts
6.2.1 By Region - Global Drug Repositioning Revenue, 2016-2021
6.2.2 By Region - Global Drug Repositioning Revenue, 2022-2027
6.2.3 By Region - Global Drug Repositioning Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Drug Repositioning Revenue, 2016-2027
6.3.2 US Drug Repositioning Market Size, 2016-2027
6.3.3 Canada Drug Repositioning Market Size, 2016-2027
6.3.4 Mexico Drug Repositioning Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Drug Repositioning Revenue, 2016-2027
6.4.2 Germany Drug Repositioning Market Size, 2016-2027
6.4.3 France Drug Repositioning Market Size, 2016-2027
6.4.4 U.K. Drug Repositioning Market Size, 2016-2027
6.4.5 Italy Drug Repositioning Market Size, 2016-2027
6.4.6 Russia Drug Repositioning Market Size, 2016-2027
6.4.7 Nordic Countries Drug Repositioning Market Size, 2016-2027
6.4.8 Benelux Drug Repositioning Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Drug Repositioning Revenue, 2016-2027
6.5.2 China Drug Repositioning Market Size, 2016-2027
6.5.3 Japan Drug Repositioning Market Size, 2016-2027
6.5.4 South Korea Drug Repositioning Market Size, 2016-2027
6.5.5 Southeast Asia Drug Repositioning Market Size, 2016-2027
6.5.6 India Drug Repositioning Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Drug Repositioning Revenue, 2016-2027
6.6.2 Brazil Drug Repositioning Market Size, 2016-2027
6.6.3 Argentina Drug Repositioning Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Repositioning Revenue, 2016-2027
6.7.2 Turkey Drug Repositioning Market Size, 2016-2027
6.7.3 Israel Drug Repositioning Market Size, 2016-2027
6.7.4 Saudi Arabia Drug Repositioning Market Size, 2016-2027
6.7.5 UAE Drug Repositioning Market Size, 2016-2027
7 Players Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Drug Repositioning Major Product Offerings
7.1.4 Teva Drug Repositioning Revenue in Global (2016-2021)
7.1.5 Teva Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Drug Repositioning Major Product Offerings
7.2.4 Novartis Drug Repositioning Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Mylan
7.3.1 Mylan Corporate Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Drug Repositioning Major Product Offerings
7.3.4 Mylan Drug Repositioning Revenue in Global (2016-2021)
7.3.5 Mylan Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Drug Repositioning Major Product Offerings
7.4.4 Johnson & Johnson Drug Repositioning Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Drug Repositioning Major Product Offerings
7.5.4 Pfizer Drug Repositioning Revenue in Global (2016-2021)
7.5.5 Pfizer Key News
7.6 Bausch Health
7.6.1 Bausch Health Corporate Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Drug Repositioning Major Product Offerings
7.6.4 Bausch Health Drug Repositioning Revenue in Global (2016-2021)
7.6.5 Bausch Health Key News
7.7 GSK
7.7.1 GSK Corporate Summary
7.7.2 GSK Business Overview
7.7.3 GSK Drug Repositioning Major Product Offerings
7.4.4 GSK Drug Repositioning Revenue in Global (2016-2021)
7.7.5 GSK Key News
7.8 ChemRar Group
7.8.1 ChemRar Group Corporate Summary
7.8.2 ChemRar Group Business Overview
7.8.3 ChemRar Group Drug Repositioning Major Product Offerings
7.8.4 ChemRar Group Drug Repositioning Revenue in Global (2016-2021)
7.8.5 ChemRar Group Key News
7.9 Glenmark
7.9.1 Glenmark Corporate Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Drug Repositioning Major Product Offerings
7.9.4 Glenmark Drug Repositioning Revenue in Global (2016-2021)
7.9.5 Glenmark Key News
7.10 Fujifilm
7.10.1 Fujifilm Corporate Summary
7.10.2 Fujifilm Business Overview
7.10.3 Fujifilm Drug Repositioning Major Product Offerings
7.10.4 Fujifilm Drug Repositioning Revenue in Global (2016-2021)
7.10.5 Fujifilm Key News
7.11 Dr. Reddy
7.11.1 Dr. Reddy Corporate Summary
7.11.2 Dr. Reddy Business Overview
7.11.3 Dr. Reddy Drug Repositioning Major Product Offerings
7.11.4 Dr. Reddy Drug Repositioning Revenue in Global (2016-2021)
7.11.5 Dr. Reddy Key News
7.12 R-Pharma
7.12.1 R-Pharma Corporate Summary
7.12.2 R-Pharma Business Overview
7.12.3 R-Pharma Drug Repositioning Major Product Offerings
7.12.4 R-Pharma Drug Repositioning Revenue in Global (2016-2021)
7.12.5 R-Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Drug Repositioning Market Opportunities & Trends in Global Market
Table 2. Drug Repositioning Market Drivers in Global Market
Table 3. Drug Repositioning Market Restraints in Global Market
Table 4. Key Players of Drug Repositioning in Global Market
Table 5. Top Drug Repositioning Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Drug Repositioning Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Drug Repositioning Revenue Share by Companies, 2016-2021
Table 8. Global Companies Drug Repositioning Product Type
Table 9. List of Global Tier 1 Drug Repositioning Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Repositioning Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma